Planet Labs Reports 42% Revenue Growth but Stock Declines
Planet Labs' stock is down 6.94% in pre-market trading, hitting a 5-day low amid broader market weakness with the Nasdaq-100 down 0.97% and the S&P 500 down 0.38%.
The company reported a 42% year-over-year revenue increase in Q1, reaching $94.2 million, surpassing analyst expectations of $90.13 million. However, despite this strong performance, the stock declined post-earnings due to investor concerns over margin outlook, as the non-GAAP gross margin fell from 59% to 56%, with expectations for a further decline next quarter. Additionally, the market reaction was influenced by the ongoing interest in SpaceX's IPO, which may have diverted attention from Planet Labs.
The significant revenue growth, driven by a surge in defense contracts, indicates robust demand for satellite services. However, the decline in stock price highlights the challenges the company faces in maintaining investor confidence, particularly in a competitive industry.
Trade with 70% Backtested Accuracy
Analyst Views on PL
About PL
About the author

- Quarterly Performance Exceeds Expectations: Planet Labs reported $94 million in sales for Q1 of fiscal 2027, reflecting a year-over-year growth of approximately 42%, surpassing Wall Street's forecast by $3.9 million, indicating strong market performance.
- Adjusted Loss Per Share Improves: The company posted a non-GAAP loss of $0.03 per share, which was $0.01 better than the average analyst estimate; however, the stock still experienced a significant decline due to bearish market sentiment.
- Full-Year Sales Target Raised: Planet Labs increased its full-year sales guidance from $415-$440 million to $425-$441 million, while also raising its adjusted gross margin forecast from 50%-52% to 52%-54%, reflecting confidence in future growth.
- Increased Macroeconomic Pressure: The U.S. added 172,000 nonfarm jobs in May, significantly above economists' expectations, raising concerns among investors about potential Federal Reserve interest rate hikes, which could pressure valuations for growth-dependent stocks like Planet Labs.
- Significant Revenue Growth: Planet Labs reported a 42% year-over-year revenue increase in Q1, reaching $94.2 million, surpassing analyst expectations of $90.13 million, indicating strong performance in the satellite imaging market, although the stock declined post-earnings due to investor concerns over margin outlook.
- Surge in Defense Revenue: Revenue from defense and intelligence grew over 65%, driving remaining performance obligations up 81% to $816 million, reflecting robust demand for satellite services and enhancing the company's competitive position in the defense sector.
- Contract Wins and Extensions: The company secured an eight-figure, one-year contract with an undisclosed international defense customer and a $21.9 million contract extension from the National Geospatial-Intelligence Agency, further solidifying its position in government contracts and expected to support future revenue growth.
- Market Reaction: Despite raising its fiscal 2027 revenue outlook to $425 million-$441 million, shares fell over 3.8% in after-hours trading, reflecting investor concerns about overall market sentiment, particularly in light of the impact from SpaceX's IPO.
- Strong Sales Growth: Planet Labs reported a 42% year-over-year increase in sales for Q1, indicating robust market demand and business expansion potential, despite the significant drop in stock price.
- Backlog Surge: The company's backlog grew by 72% to over $900 million, reflecting sustainable future revenue and increased customer confidence, even as the stock faces short-term pressure.
- Equity Financing Announcement: Management announced a $1.5 billion equity offering, which could dilute shareholder value by 9%, but this strategic move allows the company to capitalize on its high stock price to fund future growth.
- Profitability Challenges: While maintaining a net dollar retention rate of 114% and raising full-year revenue guidance to a 41% growth, the stock trades at a high 32 times sales, suggesting ongoing volatility as the company works to improve profitability.
- Stock Volatility: Planet Labs' stock surged eightfold over the past year but plummeted 35% this week due to first-quarter results falling short of market expectations, highlighting the gap between high investor expectations and actual performance.
- Equity Offering Impact: The company announced a $1.5 billion equity offering, which is expected to dilute shareholder value by approximately 9%; while this move pressures the stock in the short term, management views it as a strategic way to capitalize on the soaring share price.
- Performance Analysis: Although the first-quarter earnings exceeded average expectations, the market's lofty expectations led to a decline in stock price, reflecting investor concerns about the company's future profitability.
- Investment Strategy Advice: Given Planet Labs' current price-to-sales ratio of 32, analysts recommend that investors buy in small batches rather than going all-in, to mitigate potential stock price volatility in the future.
- Equity Offering Plan: Planet Labs has established a new at-the-market (ATM) equity offering program that allows the company to raise up to $1.5 billion by selling Class A common stock, which led to a sharp 22% drop in shares, marking the steepest decline in 21 months and reflecting investor concerns about future financing.
- Analyst Rating Upgrade: Craig-Hallum raised the price target for Planet Labs from $36 to $49 while maintaining a 'Buy' rating, indicating a potential upside of 38%, which reflects analysts' confidence in the company's strategic execution despite short-term volatility.
- Financial Performance Exceeds Expectations: Planet Labs reported quarterly revenue of $94.2 million, surpassing Wall Street's estimate of $90.13 million, with an adjusted loss per share of $0.03, better than the expected $0.04 loss, showcasing strong revenue growth.
- Market Sentiment Analysis: Despite the significant stock drop, retail sentiment on Stocktwits remained in the 'extremely bullish' zone, with message volumes surging by around 420%, indicating confidence in the company's long-term growth potential and viewing the offering as a 'necessary evil' for future expansion.
- Index Inclusion Impact: Starfighters Space, Inc. (NYSE American: FJET) announced its addition to the Russell 3000 Index effective June 29, 2026, which will enhance its visibility among institutional investors and potentially attract more index-related investments.
- Unique Aerospace Asset: The company operates a fleet of seven F-104 supersonic jets at NASA's Kennedy Space Center in Florida, capable of supporting various research and testing missions, showcasing its unique positioning in the aerospace sector.
- Increased Market Awareness: While index inclusion does not alter the company's fundamentals, it may enhance market awareness of Starfighters, particularly among investors in the public space sector, facilitating deeper due diligence.
- Commercial Conversion Challenge: The future key lies in whether Starfighters can translate its unique aerospace platform into sustained commercial activity; although the index event may broaden visibility, the core issue remains its ability to achieve long-term market recognition.










